Insights and answers you can’t get anywhere else:
Turn text to insights in seconds
Get high-quality, transparent, trustworthy results
Save months with automated analytics
Save data & IT infrastructure costs
(only pay for data you consume)
Leverage data-driven evidence at every phase of your process
Preclinical
Identify and emulate clinical trials fast
Accelerate clinical trial planning and strategy faster than any other platform.
Test thousands of products, outcomes, and patient types.
Phase 0 / Phase I
Program strategy, prioritize indications
Leverage Atropos’ MDs and clinicians to help explore data, support program strategy, and prioritize indications.
Phase II(a)
Unmet need, trial design & population
Use our experts to understand target patient profile, optimize trial design, endpoints, and comparator.
Refine TPP via unmet need.
Phase II(b) / Phase III
Launch prep, registration, efficacy
Support registration, label negotiation, reimbursement, and launch with supplementary evidence.
Compare standards of care.
Phase 4
Post-approval
Compare brands, label expansion.
Accelerate brand planning and strategy
Test thousands of products, outcomes, and patient types on Real-World Data. Rapidly respond to medical inquiry requests.
Use cases for Commercial Analytics from Atropos Health
Market Sizing & Segmentation
Prescription Trends
HCP & Account Targeting
Patient Journey
Switching Behavior
Market Share
Salesforce & Omnichannel Optimization
Launch Tracking & Uptake Analysis
Get answers about prescribing patterns, drug performance and more to inform commercial strategies and action.
Atropos Health delivers actionable insights to the most common questions from commercial teams – such as HCP behavior, new-to-brand prescription (NBRx), opportunity sizing and physician targeting.
Watch the Commercial Analytics experience video
A new standard for Commercial Analytics
Built off our clinical-grade quality and accuracy, commercial teams can now get answers to their common questions for Brand Share and Trends, HCP Behavior and Targeting, Payer Mix and Market Access, and more.

